Mark Haas, MD, PhD
Professor of Pathology
Education and Training
- Duke University, Durham, NC; MD
- Duke University, Durham, NC; PhD
- Residency in Anatomic Pathology, Yale - New Haven Medical Center, New Haven, CT
- Fellowship in Renal Pathology, Yale - New Haven Medical Center, New Haven, CT
Medical Board Certification
- Board Certified, Anatomic Pathology
Clinical and Research Interests
- Renal Pathology, including glomerular diseases and transplantation pathology
Awards and Activities
- Past-President, Renal Pathology Society
- Recipient, Jacob Churg Award, Renal Pathology Society
- Editorial Board Member, Kidney International
- Section Editor (Glomerular Diseases), Clinical Nephrology
- Haas M, Reich HN. Morphologic markers of progressive immunoglobulin A nephropathy. Adv Chronic Kidney Dis 2012; 19:107-13.
- Haas M. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum. Curr Opin Nephrol Hypertens 2012; 21:264-71.
- Mengel M, Sis B, Haas M, Colvin RB, et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012;12:563-70.
- Haas, M, Mirocha J. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am. J. Transplant 2011; 11: 2123-2131.
- Haas, M. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Clin. Nephrol. 2011;75:271-278.
Click here for a list of peer-reviewed publications by Mark Haas, MD, PhD.